Catalyst Event
Biogen Inc (BIIB) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
6/4/2026, 12:00:00 AM
Announced on 2026-06-04 that the U.S. FDA granted Breakthrough Therapy Designation for salanersen. A Medium importance is estimated as this designation significantly accelerates the regulatory path for a key asset, estimated.
Korean Translation
2026년 6월 4일, 미국 FDA가 척수성 근위축증(SMA) 치료제 살라너센에 대해 혁신치료제 지정을 승인했다고 발표함. 혁신치료제 지정의 규제적 이점을 고려하여 중요도를 'Medium'으로 예상함.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day in New York City to provide updates on strategy and long-term financial plans is scheduled. Impact estimated at >=1% as analyst days usually provide incremental updates; the event is scheduled.
9/16/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart's Q2 FY2027 earnings release is scheduled.
8/20/2026, 12:00:00 AM
Lumentum Holdings Inc (LITE) · Earnings Release
Lumentum's next earnings release for Q4 2026 is scheduled for August 11, 2026; high importance as a primary volatility driver scheduled.
8/11/2026, 12:00:00 AM
Conocophillips (COP) · Earnings Release
As quarterly results typically drive price movements exceeding 10% for major energy producers, the Q2 2026 earnings release on 2026-08-06 is scheduled.
8/6/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Second Quarter 2026 financial results and conference call are scheduled for 2026-08-06 scheduled.
8/6/2026, 12:00:00 AM
Constellation Energy Corp (CEG) · Earnings Release
Q2 2026 earnings release on August 6, 2026, with low importance estimated based on historical price movements, is expected.
8/6/2026, 12:00:00 AM